✦ LIBER ✦

Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis

✍ Scribed by Steven M. Grunberg; Montague Lane; Eric P. Lester; Kasi S. Sridhar; Joanne Mortimer; William Murphy; Polly E. Sanderson

Publisher: Springer
Year: 1993
Tongue: English
Weight: 556 KB
Volume: 32
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind comparison of

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis

✍ G. S. Harman; George A. Omura; Kevin Ryan; John D. Hainsworth; Michael B. Cramer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 149 KB

Double-blind, randomized crossover study

Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis

✍ Gini F. Fleming; Everett E. Vokes; Jan-Marie McEvilly; Linda Janisch; Donna Fran 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 227 KB

Ondansetron for the prevention of emesis

Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response study

✍ Ali Khojasteh; George Sartiano; Efstathios Tapazoglou; Eric Lester; David Gandar 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

High-dose versus low-dose metoclopramide

High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma

✍ Mathias Onsrud; Aud Moxnes; Agnes Sollien; Tone Grande; Ove Solesvik 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Randomized, double blind, dose-response

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy

✍ Edward B Rubenstein; Richard J. Gralla; John D. Hainsworth; Paul J. Hesketh; Tho 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## BACKGROUND. This double blind parallel group study assessed the acute antiemetic

Prospective randomized double-blind tria

Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis

✍ Mauve Pomeroy; James J. Fennelly; Mark Towers 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 279 KB

A prospective randomized double-blind trial comparing the butyrophenone analogue domperidone (D) and the synthetic cannabinoid nabilone (N) in the treatment of cytotoxic-induced emesis was conducted in 38 patients receiving highly emetogenic chemotherapy regimens (70% containing cisplatin). Patients